Average Co-Inventor Count = 12.74
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Sharp + Dohme Corp. (13 from 2,405 patents)
2. Merck Shapr & Dohme Corp. (1 from 1 patent)
14 patents:
1. 12459927 - Plasma kallikrein inhibitors
2. 12428397 - Factor XI activation inhibitors
3. 12304899 - Factor XI activation inhibitors
4. 11014920 - Factor XIIa inhibitors
5. 10875851 - Factor XIIa inhibitors
6. 9868733 - Azabenzimidazole tetrahydrofuran derivatives
7. 9708336 - Metallo-beta-lactamase inhibitors
8. 9556193 - Benzimidazole hexahydrofuro[3,2-b]furan derivatives
9. 9540364 - Benzimidazole tetrahydrofuran derivatives
10. 9527839 - Benzimidazole tetrahydropyran derivatives
11. 9382243 - Azabenzimidazole tetrahydropyran derivatives
12. 9290517 - Azabenzimidazole hexahydrofuro[3,2-b]furan derivatives
13. 8980929 - Substituted seven-membered heterocyclic compounds as dipeptidyl peptidase-iv inhibitors for the treatment of diabetes
14. 8796258 - Cyclic azabenzimidazole derivatives useful as anti-diabetic agents